NCT03838367 2025-09-09Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBCCytoDyn, Inc.Phase 1/2 Terminated10 enrolled 15 charts
NCT04313075 2025-07-15A Compassionate Use Study of Leronlimab in Breast CancerCytoDyn, Inc.No longer available